Search hospitals > Texas > Lubbock
Covenant Medical Center-Lakeside
Claim this profileLubbock, Texas 79410
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
46 reported clinical trials
4 medical researchers
Summary
Covenant Medical Center-Lakeside is a medical facility located in Lubbock, Texas. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Covenant Medical Center-Lakeside is involved with conducting 46 clinical trials across 130 conditions. There are 4 research doctors associated with this hospital, such as Isaac Tafur, Kiran K. Yalamanchili, Ibrahim A. Shalaby, and Gabriel Axelrud.Area of expertise
1Cancer
Global LeaderEGFR positive
Stage I
Stage II
2Lung Cancer
Global LeaderStage II
Stage I
Stage IV
Top PIs
Isaac TafurJoe Arrington Cancer Research and Treatment Center10 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Cancer
7 reported clinical trials
12 drugs studied
Kiran K. YalamanchiliCovenant Medical Center-Lakeside5 years of reported clinical research
Studies Lung Cancer
Studies Cancer
6 reported clinical trials
30 drugs studied
Ibrahim A. ShalabyCovenant Medical Center-Lakeside9 years of reported clinical research
Studies Breast Cancer
Studies Coronavirus
4 reported clinical trials
12 drugs studied
Gabriel AxelrudCovenant Medical Center-Lakeside2 years of reported clinical research
Studies Tumors
Studies Brain Tumor
3 reported clinical trials
6 drugs studied
Clinical Trials running at Covenant Medical Center-Lakeside
Non-Small Cell Lung Cancer
Lung Cancer
Squamous Cell Carcinoma
Oropharyngeal Carcinoma
Prostate Cancer
Cancer
ALK Gene Rearrangement
Laryngeal Squamous Cell Carcinoma
Oral Squamous Cell Carcinoma
Tumors
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Targeted Therapy Screening
for Lung Cancer
This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP). The type of cancer trait (biomarker) will determine to which sub-study, within this protocol, a participant will be assigned to compare new targeted cancer therapy, designed to block the growth and spread of cancer, or combinations to standard of care therapy with the ultimate goal of being able to approve new targeted therapies in this setting. In addition, the protocol includes non-match sub-studies which will include all screened patients not eligible for any of the biomarker-driven sub-studies.
Recruiting1 award Phase 2 & 313 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Covenant Medical Center-Lakeside?
Covenant Medical Center-Lakeside is a medical facility located in Lubbock, Texas. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Covenant Medical Center-Lakeside is involved with conducting 46 clinical trials across 130 conditions. There are 4 research doctors associated with this hospital, such as Isaac Tafur, Kiran K. Yalamanchili, Ibrahim A. Shalaby, and Gabriel Axelrud.